APA (7th ed.) Citation

Rodler, S., Shangqing, S., Weidenbusch, M., Staehler, M., Seliger, B., Stief, C., . . . Nuhn, P. (2016). 119 Interleukin-22 (IL-22), a T-cell secreted cytokine, contributes to renal cell carcinoma (RCC) progression and is associated with poor outcome in RCC patients. European Urology Supplements, 15(3), e119. https://doi.org/10.1016/S1569-9056(16)60121-5

Chicago Style (17th ed.) Citation

Rodler, S., S. Shangqing, M. Weidenbusch, M. Staehler, B. Seliger, C.G Stief, H-J Anders, and P. Nuhn. "119 Interleukin-22 (IL-22), a T-cell Secreted Cytokine, Contributes to Renal Cell Carcinoma (RCC) Progression and Is Associated with Poor Outcome in RCC Patients." European Urology Supplements 15, no. 3 (2016): e119. https://doi.org/10.1016/S1569-9056(16)60121-5.

MLA (9th ed.) Citation

Rodler, S., et al. "119 Interleukin-22 (IL-22), a T-cell Secreted Cytokine, Contributes to Renal Cell Carcinoma (RCC) Progression and Is Associated with Poor Outcome in RCC Patients." European Urology Supplements, vol. 15, no. 3, 2016, p. e119, https://doi.org/10.1016/S1569-9056(16)60121-5.